Evismo
Evismo AG is a Swiss Diagnostics-as-a-Service platform providing ambulatory cardiac, sleep apnea, and stress diagnostics via wearable sensors and remote specialist analysis. It enables general practitioners and specialists across Switzerland to offer in-practice diagnostics without equipment investment.
- Company typePrivate
- Founded2018
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Evismo does
Evismo AG is a privately held Swiss Diagnostics-as-a-Service company headquartered in Zurich, founded in July 2018 by Willemien van den Toorn and Alexander Panos. The company provides ambulatory diagnostic services to general practitioners and specialists across Switzerland, enabling them to offer cardiac, sleep apnea, and stress/burnout diagnostics in their practices without equipment investment. Its core portfolio comprises three insurance-reimbursed diagnostic services: CardioFlex (long-term ECG for arrhythmia detection), RespiFlex (pulse oximetry and respiratory polygraphy for sleep apnea screening and diagnosis), and StressCheck (24-hour heart rate variability analysis for stress, burnout, and sleep disorder evaluation), with an AI-assisted ECG analysis software, CardioDesk, planned for cardiologists from September 2026.
Evismo's platform, branded as evismo VitalFlex, integrates medical-grade wearable sensors (the evismoKit), a mobile application (evismoApp) for data transmission, and a web platform (evismoPlatform) for accessing specialist-prepared diagnostic reports. Vital parameters are recorded via the sensor and transmitted through the app, where Swiss-licensed specialists perform remote analysis and produce personalized diagnostic reports, typically within 24 hours to 3 days. Diagnostic services are billed through the TARDOC tariff and covered by Swiss basic health insurance; practice kits are provided free of charge. The company also sells consumable accessories (electrodes, cables, patches, nasal cannulas, and respiratory belts) through an online shop, and operates direct field sales, channel referrals via physician networks (Argomed, Medbase, Centramed, monvia), and a marketing partnership with Bayer Switzerland.
By the most recent disclosed metrics, Evismo collaborates with 1,000+ medical professionals, serves 300+ practices and clinics, and has completed 30,000+ diagnoses at a 97% reported customer satisfaction rate. The company remains Switzerland-only, with operations and deliveries restricted to domestic markets. Funding to date includes a 2018 seed round with Bittium (as both investor and sensor supplier), a September 2021 seed+ round exceeding CHF 1 million led by Zühlke Ventures AG with Business Angels Switzerland and Swiss Health Angels, and modest non-dilutive grants from Innosuisse and NTN Innovation Booster. Evismo has received the Innosuisse Certificate (February 2024), was a finalist for the Swiss Medtech Award 2025, and advanced to the second stage of the Innosuisse Scale-up Coaching program in 2025.
Evismo firmographics
Firmographics- Name
- Evismo
- Legal name
- evismo AG
- Website
- https://evismo.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Evismo AG is a Swiss Diagnostics-as-a-Service platform providing ambulatory cardiac, sleep apnea, and stress diagnostics via wearable sensors and remote specialist analysis. It enables general practitioners and specialists across Switzerland to offer in-practice diagnostics without equipment investment.
- Ownership category
- akta.pro rank
Evismo industry classification
Industry- Product category
- Medical Diagnostic Services
- NAICS
- Testing Laboratories and Services (541380)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
- akta.pro secondary industry
- Electrophysiology (Heart Rhythm) (HLAKABAC)
Keywords
Where Evismo is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Evismo business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Diagnostic Services: Medical diagnostic services (ECG, HRV, sleep apnea) billed to patients through Swiss health insurance system using TARDOC tariff. Practices receive diagnostic kits free of charge for use with patients. Analysis conducted by partner diagnostic centers and occupational health physicians.
- Medical Accessories Sales: Sale of consumable medical supplies including ECG electrodes, electrode cables, nasal cannulas, respiratory belts, and patches through e-commerce shop. Prices range from CHF 1.50 to CHF 90 for individual items.
- Software Subscriptions (Future): CardioDesk browser-based ECG analysis software planned for cardiologists from September 2026, expected to generate recurring software service revenue
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | StressCheck diagnostic service - covered by basic insurance |
| Subscription | Pay-as-you-go | RespiFlex diagnostic service - covered by basic insurance |
| Unit Pricing | Pay-as-you-go | Consumable medical accessories (electrodes, cables, sensors) |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
Evismo product offering
Product offeringCore offering
Evismo operates a Diagnostics-as-a-Service platform (evismo VitalFlex) that equips Swiss medical practices with wearable sensors to perform long-term ECG arrhythmia monitoring, sleep apnea screening, and stress/burnout HRV-based diagnostics. Practices receive diagnostic kits free of charge; recorded vital parameters are transmitted via the evismoApp to the evismoPlatform where certified Swiss specialists produce personalized diagnostic reports within 24 hours to 3 days.
Product overview
Evismo operates as a Diagnostics-as-a-Service provider centered on the evismo VitalFlex platform, which networks patients, general practitioners, specialists, and diagnostic teams through connected medical sensors and a web/mobile interface. The core service portfolio includes three main diagnostic offerings: CardioFlex for long-term ECG arrhythmia diagnosis, RespiFlex for sleep apnea screening and diagnosis, and StressCheck for HRV-based stress and burnout assessment. A fourth offering, CardioDesk (launching September 2026), extends the ecosystem with AI-assisted ECG analysis specifically for cardiologists. Each service uses the evismoKit hardware to capture vital parameters, which are transmitted via the evismoApp to the evismoPlatform where Swiss-licensed specialists produce personalized diagnostic reports. Services are available to Swiss-licensed physicians and clinics, with no investment costs required from practitioners.
Differentiator
Problem solved
Functional benefit
Brands
- CardioFlex: Long-term ECG service for diagnosis in medical practices
- RespiFlex
- StressCheck
- CardioDesk
- evismo VitalFlex
- evismoApp
- evismoPlatform
Products and services
- CardioFlex Long-term ECG (Holter) diagnostic service enabling general practitioners and specialists to diagnose cardiac arrhythmias in their practice without investment costs. Vital parameters are recorded via sensor, transmitted to the evismoApp, and analyzed by specialists who provide a personal diagnostic report.
- RespiFlex Sleep apnea screening and diagnosis service combining extended pulse oximetry (screening) with full respiratory polygraphy (diagnosis) using the same overnight measurement. Screening report delivered within 24 hours and full diagnostic report from a Swiss sleep center within 3 days.
- StressCheck Stress, burnout, and sleep disorder diagnostic service using 24-hour heart rate variability (HRV) measurement via ECG sensor. Analyzed remotely by occupational health specialists producing a detailed report with treatment recommendations covering energy, regeneration, fatigue, sleep patterns, and heart rhythm.
- CardioDesk AI-assisted ECG analysis software for cardiologists. Browser-based platform for managing long-term ECG recordings, validating arrhythmias with full raw data access, and creating reports with AI-generated drafts.
- Medical Accessories Shop E-commerce shop selling consumable medical accessories for diagnostic services, including ECG electrodes (CHF 1.50 to CHF 90), electrode cables, nasal cannulas, respiratory belts, USB cables, and patches. Available to existing medical practice customers.
Quantifiable outcome
- 300+ practices and clinics using Evismo services
- +4 more outcomes
Companies that use Evismo
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles5 records
Evismo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Evismo partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Bayer (Switzerland)minorMarketing partnership with Bayer Schweiz AG announced May 31, 2023. Nature of collaboration involves joint go-to-market activities.
- monviaminorPartnership for distributing Evismo diagnostic services to monvia patients and customers. Announced July 11, 2022.
- Argomed Ärzte AGcoreStrategic partnership bringing cardiac arrhythmia diagnostics to Argomed physician network practices. Evismo CardioFlex available across Argomed HausarztFORUM network.
- SIHLMEDcoreIntegrative medicine center using Evismo StressCheck for HRV analysis with patients since March 2024. Dr. Philipp Katumba serves as chief physician and testimonial reference.
- Hofklinik für Wach- & SchlafmedizincoreSleep medicine clinic partner providing diagnostic evaluation services for Evismo RespiFlex. Dr. Heydy Lorena Gonzalez serves as chief physician providing expert commentary.
- HNO ZürichbergminorENT clinic serving as diagnostic partner for sleep apnea evaluation using Evismo RespiFlex platform.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Evismo competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights6 records
Customer concentration
Evismo social profiles
Digital presenceEvismo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evismo leadership team
Management profileNumber of profiles
Profiles4 records
Evismo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evismo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evismo
What does Evismo do?
Evismo operates a Diagnostics-as-a-Service platform (evismo VitalFlex) that equips Swiss medical practices with wearable sensors to perform long-term ECG arrhythmia monitoring, sleep apnea screening, and stress/burnout HRV-based diagnostics. Practices receive diagnostic kits free of charge; recorded vital parameters are transmitted via the evismoApp to the evismoPlatform where certified Swiss specialists produce personalized diagnostic reports within 24 hours to 3 days.
Is Evismo a public or private company?
Evismo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Evismo founded?
Evismo was founded in 2018. It employs 11 to 50 people.
Where is Evismo based?
Evismo is headquartered in Zürich, Switzerland, in the Europe region.
How does Evismo make money?
Three revenue lines are on record. Diagnostic Services are the primary driver. The others are medical Accessories Sales and software Subscriptions (Future).
Does Evismo have an API?
No public API is recorded for Evismo.
What industry is Evismo in?
Evismo's product category is Medical Diagnostic Services. Its primary akta.pro industry code is HLALAGAF, Pulmonology & Sleep Medicine Telemedicine Platforms, with a secondary code of HLAKABAC, Electrophysiology (Heart Rhythm). Its NAICS code is 541380 and its SIC code is 8071.